title: A numerical analysis model for the interpretation of in vivo platelet consumption data.
abstract: Unlike anemias, most thrombocytopenias cannot be separated into those due to impaired production and those due to accelerated consumption. While rapid clearance of labeled platelets from the bloodstream can be followed in thrombocytopenic individuals, no model exists for quantitatively inferring from autologous or allogeneic platelet consumption data what changes in random consumption, lifespan dependent consumption, and platelet production rate may have caused the thrombocytopenia. Here we describe a numerical analysis model which resolves these issues. The model applies three parameter values (a random consumption rate constant, a lognormally-distributed platelet lifespan, and the standard deviation of the latter) to a matrix comprising a series of platelet cohorts which are sequentially produced and fractionally consumed in a series of time intervals. The cohort platelet counts achieved after equilibration of production and consumption both enumerate the population age distribution and sum to the population platelet count. Continued platelet consumption after production is halted then serves to model in vivo platelet consumption data, with consumption rate in the first such interval defining the equilibrium platelet production rate. We use a least squares fitting procedure to find parameter values which best fit observed platelet consumption data obtained in WT and thrombocytopenic WASP(-) mice. Equilibrium platelet age distributions are then 'grafted' into the matrix to allow modeling of the consumption of WT platelets in WASP(-) recipients, and vice versa. The optimal parameter values obtained indicate that random WT platelet consumption accounts for a larger fraction of platelet turnover than was previously suspected. Platelet WASP deficiency accelerates random consumption, and a trans effect of recipient WASP deficiency contributes to this. Application of the model to clinical data will allow distinctions to be made between thrombocytopenias due primarily to impaired platelet production and those due to acceleration of random or lifespan-dependent platelet consumption.
authors: Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, TN, USA. tstrom@uthsc.edu
authors: Ted S
authors: TS
authors: Strom
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D003627:Data Interpretation, Statistical; D007700:Kinetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D013921:Thrombocytopenia / Q000097:blood
references: Eur J Haematol. 1989 Mar;42(3):259-64
references: 2924888
references: Blood. 2001 Aug 15;98(4):1019-27
references: 11493447
references: Transfusion. 2006 Feb;46(2):257-64
references: 16441604
references: Blood. 2010 Sep 9;116(10):1776-8
references: 20530288
references: Nat Rev Immunol. 2011 Apr;11(4):264-74
references: 21436837
references: Exp Hematol. 2005 Apr;33(4):443-51
references: 15781335
references: Science. 2012 Jan 20;335(6066):338-41
references: 22223740
references: J Immunol. 2012 Jul 15;189(2):916-23
references: 22706078
references: Br J Haematol. 2010 Dec;151(5):477-87
references: 20950403
references: Blood. 1980 Feb;55(2):243-52
references: 6444359
references: J Thromb Haemost. 2009 Nov;7(11):1759-66
references: 19691483
references: Br J Haematol. 1999 Sep;106(4):875-83
references: 10519987
references: Am J Hematol. 2011 Nov;86(11):909-13
references: 21948335
references: Exp Hematol. 2009 Nov;37(11):1353-63
references: 19733207
references: Br J Haematol. 1969 Oct;17(4):373-88
references: 5346410
references: Platelets. 2013;24(4):288-96
references: 22812495
references: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13457-62
references: 19633185
references: J Lab Clin Med. 1991 Dec;118(6):546-54
references: 1744503
references: Br J Haematol. 1991 Oct;79(2):271-6
references: 1958485
references: Blood. 2009 Nov 19;114(21):4729-37
references: 19692704
references: Ann N Y Acad Sci. 1972 Oct 27;201:437-44
references: 4265132
references: Blood. 2008 Mar 15;111(6):3249-56
references: 18096766
references: J Physiol. 1946 Jul 15;105:16
references: 21065025
references: PLoS One. 2011;6(11):e26657
references: 22073181
references: Immunity. 1998 Jul;9(1):81-91
references: 9697838
references: Blood. 2006 Jul 1;108(1):134-40
references: 16522820
references: Blood. 2008 Oct 15;112(8):3148-53
references: 18684867
references: Blood. 1977 Dec;50(6):1137-44
references: 922161
references: Transfus Med Rev. 2004 Jul;18(3):153-67
references: 15248165
references: Blood. 1986 Jan;67(1):86-92
references: 3940554
references: Cell. 2007 Mar 23;128(6):1173-86
references: 17382885
references: Blood. 1985 Nov;66(5):1105-9
references: 4052629
references: Br J Haematol. 1999 Nov;107(2):254-62
references: 10583210
references: Curr Opin Hematol. 2010 Nov;17(6):585-9
references: 20729731
references: Transfusion. 2004 Dec;44(12):1732-40
references: 15584988
references: Eur J Haematol. 2010 Aug;85(2):158-63
references: 20477866
references: Transfusion. 2005 Aug;45(2 Suppl):72S-80S
references: 16086792
references: Blood. 1951 Dec;6(12):1284-92
references: 14886401
references: Blood. 1993 Nov 15;82(10):2961-6
references: 8219187
references: Transfus Med Hemother. 2012 Feb;39(1):5-8
references: 22896760
references: Thromb Diath Haemorrh. 1971 Dec 31;26(3):431-48
references: 5144959
references: Blood. 1996 Mar 15;87(6):2162-70
references: 8630375
references: Transfusion. 2005 Jul;45(7):1143-50
references: 15987360
references: Exp Hematol. 2008 May;36(5):609-23
references: 18346836
references: Am J Hematol. 1986 Nov;23(3):231-8
references: 3766525
references: J Nucl Med. 1986 Jul;27(7):1192-201
references: 3088224